Systematic Review of Membrane Components of Gram-Positive Bacteria Responsible as Pyrogens for Inducing Human Monocyte/Macrophage Cytokine Release

Fifty years after the elucidation of lipopolysaccharides (LPS, endotoxin) as the principal structure of Gram-negative bacteria activating the human immune system, its Gram-positive counterpart is still under debate. Pyrogen tests based on the human monocyte activation have been validated for LPS detection as an alternative to the rabbit test and, increasingly, the limulus amebocyte lysate test. For full replacement, international validations with non-endotoxin pyrogens are in preparation. Following evidence-based medicine approaches, a systematic review of existing evidence as to the structural nature of the Gram-positive pyrogen was undertaken. For the three major constituents suggested, i.e., peptidoglycan, lipoteichoic acids (LTA), and bacterial lipoproteins (LP), the questions to be answered and a search strategy for relevant literature was developed, starting in MedLine. The evaluation was based on the Koch–Dale criteria for a mediator of an effect. A total of 380 articles for peptidoglycan, 391 for LP, and 285 for LTA were retrieved of which 12, 8, and 24, respectively, fulfilled inclusion criteria. The compiled data suggest that for peptidoglycan two Koch–Dale criteria are fulfilled, four for LTA, and two for bacterial LP. In conclusion, based on the best currently available evidence, LTA is the only substance that fulfills all criteria. LTA has been isolated from a large number of bacteria, results in cytokine release patterns inducible also with synthetic LTA. Reduction in bacterial cytokine induction with an inhibitor for LTA was shown. However, this systematic review cannot exclude the possibility that other stimulatory compounds complement or substitute for LTA in being the counterpart to LPS in some Gram-positive bacteria.

[1]  D. Savage,et al.  Lipoteichoic acids in Lactobacillus strains that colonize the mouse gastric epithelium , 1986, Applied and environmental microbiology.

[2]  K. Knox,et al.  Characterization of group N streptococcus lipoteichoic acid , 1975, Infection and immunity.

[3]  K. Knox,et al.  Serological Studies on the Teichoic Acids of Lactobacillus plantarum , 1972, Infection and immunity.

[4]  J. Baddiley,et al.  Extraction and purification of lipoteichoic acids from Gram-positive bacteria. , 1975, Carbohydrate research.

[5]  T. Lehner,et al.  Immunisation of rhesus monkeys with Streptococcus mutans, Lactobacillus acidophilus and lipoteichoic acid for protection against dental caries. , 1982, Journal of medical microbiology.

[6]  J. Abrams,et al.  Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. , 1992, Journal of immunology.

[7]  R. Arakaki,et al.  A lipoteichoic acid fraction of Enterococcus hirae activates cultured human monocytic cells via a CD14-independent pathway to promote cytokine production, and the activity is inhibited by serum components. , 1998, FEMS immunology and medical microbiology.

[8]  T. Hartung,et al.  Macroamphiphilic Components of Thermophilic Actinomycetes: Identification of Lipoteichoic Acid in Thermobifida fusca , 2008, Journal of bacteriology.

[9]  T. Hartung,et al.  Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. , 2001 .

[10]  C. Lowenstein,et al.  Pathogen Recognition by Toll-like Receptor 2 Activates Weibel-Palade Body Exocytosis in Human Aortic Endothelial Cells* , 2007, Journal of Biological Chemistry.

[11]  A. Halpern,et al.  The Sorcerer II Global Ocean Sampling Expedition: Northwest Atlantic through Eastern Tropical Pacific , 2007, PLoS biology.

[12]  William Wiley Navarre,et al.  Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope , 1999, Microbiology and Molecular Biology Reviews.

[13]  I. Azuma,et al.  Structural studies on lipoteichoic acids from four Listeria strains , 1986, Journal of bacteriology.

[14]  W. Fischer,et al.  Separation of the poly(glycerophosphate) lipoteichoic acids of Enterococcus faecalis Kiel 27738, Enterococcus hirae ATCC 9790 and Leuconostoc mesenteroides DSM 20343 into molecular species by affinity chromatography on concanavalin A. , 1991, European journal of biochemistry.

[15]  A. Tomasz,et al.  Pneumococcal Forssman antigen. A choline-containing lipoteichoic acid. , 1973, The Journal of biological chemistry.

[16]  D. Jelley-Gibbs,et al.  Lipoteichoic Acid Inhibits Interleukin-2 (IL-2) Function by Direct Binding to IL-2 , 2001, Clinical Diagnostic Laboratory Immunology.

[17]  T. Hartung,et al.  Comment on “Not Lipoteichoic Acid but Lipoproteins Appear to Be the Dominant Immunobiologically Active Compounds in Staphylococcus aureus” , 2006, The Journal of Immunology.

[18]  F. Re,et al.  Commercial peptidoglycan preparations are contaminated with superantigen‐like activity that stimulates IL‐17 production , 2008, Journal of leukocyte biology.

[19]  T. Hartung,et al.  Comparison of Lipoteichoic Acid from Different Serotypes of Streptococcus pneumoniae* , 2006, Journal of Biological Chemistry.

[20]  T. Hartung,et al.  Cytokine induction by Gram-positive bacteria. , 2008, Immunobiology.

[21]  O. Holst,et al.  Opsonic Antibodies to Enterococcus faecalis Strain 12030 Are Directed against Lipoteichoic Acid , 2006, Infection and Immunity.

[22]  J. Verhoef,et al.  Chemiluminescence of human polymorphonuclear leucocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermidis. , 1993, Journal of medical microbiology.

[23]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[24]  G. Shockman,et al.  Cellular localization of lipoteichoic acid in Streptococcus faecalis , 1975, Journal of bacteriology.

[25]  J. Metcalf,et al.  Bacillus anthracis Peptidoglycan Stimulates an Inflammatory Response in Monocytes through the p38 Mitogen-Activated Protein Kinase Pathway , 2008, PloS one.

[26]  L. Kremer,et al.  Mycobacterium tuberculosis Lipomannan Induces Apoptosis and Interleukin-12 Production in Macrophages , 2004, Infection and Immunity.

[27]  S. Foster,et al.  Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model , 2000, Infection and Immunity.

[28]  S. Kusumoto,et al.  Cytokine-inducing glycolipids in the lipoteichoic acid fraction from Enterococcus hirae ATCC 9790. , 1995, FEMS immunology and medical microbiology.

[29]  J. Bertin,et al.  Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan , 2003, Science.

[30]  L. P. Sousa,et al.  Meso-diaminopimelic acid and meso-lanthionine, amino acids specific to bacterial peptidoglycans, activate human epithelial cells through NOD1. , 2008, The Journal of Immunology.

[31]  D. Stechschulte,et al.  Histamine induces Toll‐like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram‐positive and Gram‐negative bacterial cell wall components , 2004, Immunology.

[32]  R. Schumann,et al.  Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids. , 2008, Immunobiology.

[33]  U. Göbel,et al.  Lipoteichoic Acid (LTA) of Streptococcus pneumoniaeand Staphylococcus aureus Activates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved* , 2003, The Journal of Biological Chemistry.

[34]  Sun-Hee Kim,et al.  Isolation and structural analysis of bamylocin A, novel lipopeptide from Bacillus amyloliquefaciens LP03 having antagonistic and crude oil-emulsifying activity , 2007, Archives of Microbiology.

[35]  T. Hartung,et al.  Induction of Cross-Tolerance by Lipopolysaccharide and Highly Purified Lipoteichoic Acid Via Different Toll-Like Receptors Independent of Paracrine Mediators1 , 2001, The Journal of Immunology.

[36]  M. Dehouck,et al.  Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood–brain barrier disruption through glia activation: Role of pro-inflammatory cytokines and nitric oxide , 2006, Neuroscience.

[37]  J. Bonmatin,et al.  Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation and structural evaluation by NMR and mass spectrometry. , 1999, The Journal of antibiotics.

[38]  Sarah K. Meadows,et al.  TLRs Mediate IFN-γ Production by Human Uterine NK Cells in Endometrium1 , 2006, The Journal of Immunology.

[39]  Ping-Chang Yang,et al.  Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: The role of TLR2 and NOD2 , 2007, Immunology and cell biology.

[40]  K. Brandenburg,et al.  Innate recognition of bacteria: engagement of multiple receptors. , 2002, Critical reviews in immunology.

[41]  Bozhong Mu,et al.  Isolation and characterization of a C12‐lipopeptide produced by Bacillus subtilis HSO 121 , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[42]  W. Fischer,et al.  Isomalto-oligosaccharide-containing lipoteichoic acid of Streptococcus sanguis. Microheterogeneity and distribution of chain substituents. , 1993, European journal of biochemistry.

[43]  T. Beveridge Structures of Gram-Negative Cell Walls and Their Derived Membrane Vesicles , 1999, Journal of bacteriology.

[44]  S. M. Sullivan,et al.  Genetic determination of the effect of post-translational modification on the innate immune response to the 19 kDa lipoprotein of Mycobacterium tuberculosis , 2009, BMC Microbiology.

[45]  V. Dennis,et al.  Autocrine and Exocrine Regulation of Interleukin-10 Production in THP-1 Cells Stimulated with Borrelia burgdorferi Lipoproteins , 2002, Infection and Immunity.

[46]  Sang Su Woo,et al.  Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines , 2007, Journal of leukocyte biology.

[47]  F. Fiedler,et al.  Occurrence and structure of lipoteichoic acids in the genus Staphylococcus , 1990, Archives of Microbiology.

[48]  Thomas Hartung,et al.  Cell Activation of Human Macrophages by Lipoteichoic Acid Is Strongly Attenuated by Lipopolysaccharide-binding Protein* , 2006, Journal of Biological Chemistry.

[49]  R. Balakrishna,et al.  Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. , 2008, Immunology letters.

[50]  W. Fischer Molecular analysis of lipid macroamphiphiles by hydrophobic interaction chromatography, exemplified with lipoteichoic acids. , 1993, Analytical biochemistry.

[51]  T. F. Murray,et al.  The Origin of the Synergistic Effect of Muramyl Dipeptide with Endotoxin and Peptidoglycan* , 2002, The Journal of Biological Chemistry.

[52]  S. D. Hogg,et al.  Competitive binding of calcium and magnesium to streptococcal lipoteichoic acid. , 1995, Biochimica et biophysica acta.

[53]  Thomas Hartung,et al.  Lipopolysaccharide- and Lipoteichoic Acid-Induced Tolerance and Cross-Tolerance: Distinct Alterations in IL-1 Receptor-Associated Kinase1 , 2002, The Journal of Immunology.

[54]  I. Sutcliffe,et al.  Atypical lipoteichoic acids of gram-positive bacteria , 1991, Journal of bacteriology.

[55]  E. Latz,et al.  Lipopolysaccharide-binding protein. , 2000, Chemical immunology.

[56]  P. Janmey,et al.  Extracellular Gelsolin Binds Lipoteichoic Acid and Modulates Cellular Response to Proinflammatory Bacterial Wall Components1 , 2008, The Journal of Immunology.

[57]  T. Alatossava,et al.  Characterization of Lipoteichoic Acids as Lactobacillus delbrueckii Phage Receptor Components , 2004, Journal of bacteriology.

[58]  H. O. D. op den Camp,et al.  Structure of the lipoteichoic acids from Bifidobacterium bifidum spp. pennsylvanicum. , 1984, Biochimica et biophysica acta.

[59]  E. Bröcker,et al.  Production of IL-12 and IL-18 in human dendritic cells upon infection by Listeria monocytogenes. , 2003, FEMS immunology and medical microbiology.

[60]  T. Hartung,et al.  Synthetic Lipoteichoic Acid from Staphylococcus aureus Is a Potent Stimulus of Cytokine Release , 2002, The Journal of experimental medicine.

[61]  K. Cox,et al.  Lipoteichoic Acid Synergizes with Glycosphingolipids To Potently Stimulate Secretion of Interleukin-6 from Human Blood Cells , 2008, Clinical and Vaccine Immunology.

[62]  S. Echigo,et al.  A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-agonistic activities, resulting in synergistic activation of human monocytic cells , 2008, Innate immunity.

[63]  T. Hartung,et al.  Different Staphylococcus aureus whole bacteria mutated in putative pro-inflammatory membrane components have similar cytokine inducing activity. , 2011, Immunobiology.

[64]  B. Andersson,et al.  Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes. , 2005, Cytokine.

[65]  H. Redmond,et al.  Induction of Bacterial Lipoprotein Tolerance Is Associated with Suppression of Toll-like Receptor 2 Expression* , 2002, The Journal of Biological Chemistry.

[66]  W. Vollmer,et al.  The Architecture of the Murein (Peptidoglycan) in Gram-Negative Bacteria: Vertical Scaffold or Horizontal Layer(s)? , 2004, Journal of bacteriology.

[67]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[68]  S. Cummings,et al.  Phenotypic variation in Streptomyces sp. DSM 40537, a lipoteichoic acid producing actinomycete , 2009, Letters in applied microbiology.

[69]  E. Ito,et al.  Comparative studies of lipoteichoic acids from several Bacillus strains , 1986, Journal of bacteriology.

[70]  F. Fiedler,et al.  Alanine ester-containing native lipoteichoic acids do not act as lipoteichoic acid carrier. Isolation, structural and functional characterization. , 1980, The Journal of biological chemistry.

[71]  F. Sakai,et al.  WS1279, a novel lipopeptide isolated from Streptomyces willmorei. Biological activities. , 1993, The Journal of antibiotics.

[72]  A. Archibald,et al.  Lipoteichoic acid and lipoteichoic acid carrier in Staphylococcus aureus H , 1975, FEBS letters.

[73]  T. Hartung,et al.  Use of Synthetic Derivatives To Determine the Minimal Active Structure of Cytokine-Inducing Lipoteichoic Acid , 2007, Clinical and Vaccine Immunology.

[74]  Sebastian Hoffmann,et al.  International validation of novel pyrogen tests based on human monocytoid cells. , 2005, Journal of immunological methods.

[75]  Yimou Wu,et al.  Mycoplasma genitalium Lipoproteins Induce Human Monocytic Cell Expression of Proinflammatory Cytokines and Apoptosis by Activating Nuclear Factor κB , 2008, Mediators of inflammation.

[76]  T. Theodore,et al.  Lipoteichoic Acid Localization in Mesosomal Vesicles of Staphylococcus aureus , 1974, Journal of bacteriology.

[77]  G. Jung,et al.  Physicochemical and biological analysis of synthetic bacterial lipopeptides : Validity of the concept of ’ endotoxic conformation ’ 1 , 2003 .

[78]  K. Knox,et al.  Comparative Studies on the Isolation of Membrane Lipoteichoic Acid from Lactobacillus fermenti , 1973, Journal of bacteriology.

[79]  J. Mcghee,et al.  Chemical properties and immunobiological activities of streptococcal lipoteichoic acids. , 1985, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

[80]  L. L. Jackson,et al.  Lipoteichoic acid from Listeria monocytogenes , 1983, Journal of bacteriology.

[81]  T. Hartung,et al.  Internalization and Coreceptor Expression Are Critical for TLR2-Mediated Recognition of Lipoteichoic Acid in Human Peripheral Blood , 2010, The Journal of Immunology.

[82]  M. Housaindokht,et al.  Isolation, characterization, and investigation of surface and hemolytic activities of a lipopeptide biosurfactant produced by Bacillus subtilis ATCC 6633. , 2005, Journal of microbiology.

[83]  K. Fukase,et al.  Meso-Diaminopimelic Acid and Meso-Lanthionine, Amino Acids Specific to Bacterial Peptidoglycans, Activate Human Epithelial Cells through NOD11 , 2006, The Journal of Immunology.

[84]  L. Ingram,et al.  Purification of lipoteichoic acids by using phosphatidyl choline vesicles , 1978, Infection and immunity.

[85]  Mardas Daneshian,et al.  Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood. , 2009, ALTEX.

[86]  Sebastian Hoffmann,et al.  International validation of pyrogen tests based on cryopreserved human primary blood cells. , 2006, Journal of immunological methods.

[87]  B. Lindberg,et al.  Structural studies of a teichoic acid from Streptococcus agalactiae type III. , 1986, Carbohydrate research.

[88]  P. Owen,et al.  Isolation and characterization of a mannan from mesosomal membrane vesicles of Micrococcus lysodeikticus. , 1975, Biochimica et biophysica acta.

[89]  S. Han,et al.  Monoacyl Lipoteichoic Acid from Pneumococci Stimulates Human Cells but Not Mouse Cells , 2005, Infection and Immunity.

[90]  T. Hartung,et al.  Structural Decomposition and Heterogeneity of Commercial Lipoteichoic Acid Preparations , 2002, Infection and Immunity.

[91]  J. Beuth,et al.  Stimulation of human monocyte chemiluminescence by staphylococcal lipoteichoic acid , 2004, Medical Microbiology and Immunology.

[92]  D. Philpott,et al.  Toll‐like receptor 2‐dependent bacterial sensing does not occur via peptidoglycan recognition , 2004, EMBO reports.

[93]  X. You,et al.  [Mycoplasma genitalium lipid-associated membrane proteins induce human monocytic cell express proinflammatory cytokines and apoptosis by activating nuclear factor kappaB]. , 2007, Wei sheng wu xue bao = Acta microbiologica Sinica.

[94]  K. Fukase,et al.  Muramyldipeptide and diaminopimelic acid‐containing desmuramylpeptides in combination with chemically synthesized Toll‐like receptor agonists synergistically induced production of interleukin‐8 in a NOD2‐ and NOD1‐dependent manner, respectively, in human monocytic cells in culture , 2004, Cellular microbiology.

[95]  T. Hartung,et al.  Definition of Structural Prerequisites for Lipoteichoic Acid-Inducible Cytokine Induction by Synthetic Derivatives1 , 2003, The Journal of Immunology.

[96]  W. Fischer,et al.  Hydrophobic interaction chromatography fractionates lipoteichoic acid according to the size of the hydrophilic chain: a comparative study with anion-exchange and affinity chromatography for suitability in species analysis. , 1992, Analytical biochemistry.

[97]  Thomas Hartung,et al.  Cytokine induction by purified lipoteichoic acids from various bacterial species – Role of LBP, sCD14, CD14 and failure to induce IL‐12 and subsequent IFN‐γ release , 2002, European journal of immunology.

[98]  W. Fischer 'Lipoteichoic acid' of Bifidobacterium bifidum subspecies pennsylvanicum DSM 20239. A lipoglycan with monoglycerophosphate side chains. , 1987, European journal of biochemistry.

[99]  G. Teti,et al.  Mediation of Staphylococcus saprophyticus adherence to uroepithelial cells by lipoteichoic acid , 1987, Infection and immunity.

[100]  S. Sugawara,et al.  Priming of human oral epithelial cells by interferon-gamma to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans. , 2002, Journal of medical microbiology.

[101]  W. Fischer,et al.  Improved preparation of lipoteichoic acids. , 1983, European journal of biochemistry.

[102]  T. Hartung,et al.  MDP and other muropeptides--direct and synergistic effects on the immune system. , 2006, Journal of endotoxin research.

[103]  T. Hartung,et al.  Lipoteichoic acid from Lactobacillus plantarum elicits both the production of interleukin-23p19 and suppression of pathogen-mediated interleukin-10 in THP-1 cells. , 2007, FEMS immunology and medical microbiology.

[104]  D. Chung,et al.  Lipoteichoic Acid Isolated from Lactobacillus plantarum Inhibits Lipopolysaccharide-Induced TNF-α Production in THP-1 Cells and Endotoxin Shock in Mice1 , 2008, The Journal of Immunology.

[105]  M. Okuhara,et al.  WS1279, a novel lipopeptide isolated from Streptomyces willmorei. Fermentation, isolation and physico-chemical properties. , 1993, The Journal of antibiotics.

[106]  R. Nau,et al.  Enzyme Immunoassay Detecting Teichoic and Lipoteichoic Acids versus Cerebrospinal Fluid Culture and Latex Agglutination for Diagnosis of Streptococcus pneumoniae Meningitis , 1998, Journal of Clinical Microbiology.

[107]  W. Fischer,et al.  Distribution analyses of chain substituents of lipoteichoic acids by chemical degradation. , 1989, European journal of biochemistry.

[108]  Thomas Hartung,et al.  An in vitro pyrogen safety test for immune-stimulating components on surfaces. , 2007, Biomaterials.

[109]  J. Peter-Katalinic,et al.  The structure of pneumococcal lipoteichoic acid. Improved preparation, chemical and mass spectrometric studies. , 1992, European journal of biochemistry.

[110]  J. H. Pollack,et al.  D-alanyl-lipoteichoic acid in Lactobacillus casei: secretion of vesicles in response to benzylpenicillin. , 1992, Journal of general microbiology.

[111]  W. Fischer,et al.  Trihexosyldiacylglycerol and Acyltrihexosyldiacylglycerol as Lipid Anchors of the Lipoteichoic Acid of Lactobacillus casei DSM 20021 , 1978, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[112]  W. Fischer,et al.  Small and medium-angle X-ray analysis of bacterial lipoteichoic acid phase structure. , 1991, European journal of biochemistry.

[113]  D. Morrison,et al.  Commercial Preparations of Lipoteichoic Acid Contain Endotoxin That Contributes to Activation of Mouse Macrophages In Vitro , 2001, Infection and Immunity.

[114]  J. Dengjel,et al.  Staphylococcus aureus Deficient in Lipidation of Prelipoproteins Is Attenuated in Growth and Immune Activation , 2005, Infection and Immunity.

[115]  W. Fischer,et al.  Isomalto-oligosaccharide-containing lipoteichoic acid of Streptococcus sanguis. Basic structure. , 1993, European journal of biochemistry.

[116]  T. Evans,et al.  Butanol-extracted lipoteichoic acid induces in vivo leukocyte adhesion. , 2007, Biochemical and biophysical research communications.

[117]  B. Beutler TLRs and innate immunity. , 2009, Blood.

[118]  G. Jung,et al.  Lipopeptide structure determines TLR2 dependent cell activation level , 2005, The FEBS journal.

[119]  J. Maurer,et al.  Molecular analysis of lipoteichoic acid from Streptococcus agalactiae , 1991, Journal of bacteriology.

[120]  J. Wain,et al.  Effect of Deletion or Overexpression of the 19-Kilodalton Lipoprotein Rv3763 on the Innate Response to Mycobacterium tuberculosis , 2005, Infection and Immunity.

[121]  J. M. ten Cate,et al.  Lipoteichoic Acid Inhibits Remineralization of Artificial Subsurface Lesions and Surface-softened Enamel , 1995, Journal of dental research.

[122]  T. Nealon,et al.  Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease , 1983, Infection and immunity.

[123]  N. McElvaney,et al.  TLR-Induced Inflammation in Cystic Fibrosis and Non-Cystic Fibrosis Airway Epithelial Cells1 , 2005, The Journal of Immunology.

[124]  S. D. De Keersmaecker,et al.  Functional Analysis of d-Alanylation of Lipoteichoic Acid in the Probiotic Strain Lactobacillus rhamnosus GG , 2007, Applied and Environmental Microbiology.

[125]  Isolation and partial characterisation of the Triton X-100 solubilised protein antigen from Mycobacterium tuberculosis. , 1999, Journal of medical microbiology.

[126]  CHEMICAL FACTORS IN THE CONTROL OF THE CIRCULATION , 1929, British medical journal.

[127]  S. V. van Deventer,et al.  Distribution and Kinetics of Lipoprotein-Bound Lipoteichoic Acid , 2003, Infection and Immunity.

[128]  Osamu Takeuchi,et al.  Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus1 , 2005, The Journal of Immunology.

[129]  V. Dennis,et al.  Interleukin-10 Modulates Proinflammatory Cytokines in the Human Monocytic Cell Line THP-1 Stimulated withBorrelia burgdorferi Lipoproteins , 2000, Infection and Immunity.

[130]  W. Fischer,et al.  On the basic structure of poly(glycerophosphate) lipoteichoic acids. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[131]  Thomas Hartung,et al.  Novel Pyrogen Tests Based on the Human Fever Reaction , 2001, Alternatives to laboratory animals : ATLA.

[132]  J. Marshall,et al.  Cutting Edge: Distinct Toll-Like Receptor 2 Activators Selectively Induce Different Classes of Mediator Production from Human Mast Cells 12 , 2003, The Journal of Immunology.

[133]  K. Yokoyama,et al.  Structure and glycosylation of lipoteichoic acids in Bacillus strains , 1989, Journal of bacteriology.

[134]  D. W. Kim,et al.  Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. , 2009, International immunopharmacology.

[135]  A. Tomasz,et al.  Activation of the alternative complement pathway by pneumococcal lipoteichoic acid , 1985, Infection and immunity.

[136]  G. Mancuso,et al.  Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid , 1994, Infection and immunity.

[137]  P. Godowski,et al.  Toll-Like Receptor 2 Ligands as Adjuvants for Human Th1 Responses1 , 2003, The Journal of Immunology.

[138]  K. Hellingwerf,et al.  Isolation and characterization of lipoteichoic acid, a cell envelope component involved in preventing phage adsorption, from Lactococcus lactis subsp. cremoris SK110 , 1990, Journal of bacteriology.

[139]  S. Akira,et al.  Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.

[140]  T. Hartung,et al.  Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[141]  J. Wouters,et al.  Lipoteichoic acid from Bacillus subtilis subsp. niger WM: isolation and effects on cell wall autolysis and turnover , 1987, Journal of bacteriology.

[142]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[143]  M. Nagaoka,et al.  Structure of macroamphiphiles from several Bifidobacterium strains , 1990, Journal of bacteriology.

[144]  T. Hartung,et al.  Polypropylene glycol is a selective binding inhibitor for LTA and other structurally related TLR2 agonists , 2008, European journal of immunology.

[145]  T. Hartung,et al.  Presentation of lipoteichoic acid potentiates its inflammatory activity. , 2008, Immunobiology.

[146]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[147]  T. Hartung,et al.  A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues. , 2006, Bioorganic & medicinal chemistry.

[148]  S. Dower,et al.  Toll-Like Receptor (TLR)2 and TLR4 Agonists Regulate CCR Expression in Human Monocytic Cells1 , 2004, The Journal of Immunology.

[149]  U. Göbel,et al.  Lipopolysaccharide Binding Protein Binds to Triacylated and Diacylated Lipopeptides and Mediates Innate Immune Responses1 , 2004, The Journal of Immunology.